OHE’s Koonal Shah gave a presentation on the evidence of societal support for an end of life premium at the Pharmaccess Leaders Forum in Milan on 5th May. On 5th May 2017, OHE’s Koonal Shah attended and presented at the…
OHE’s Koonal Shah gave a presentation on the evidence of societal support for an end of life premium at the Pharmaccess Leaders Forum in Milan on 5th May.
On 5th May 2017, OHE’s Koonal Shah attended and presented at the Pharmaccess Leaders Forum in Milan, Italy. His presentation examined the extent of societal support for an end of life premium – that is, the extent to which society places special value on health gains for patients with short life expectancy.
Koonal began by providing background on QALY weighting and the policy context in England, focusing on NICE’s appraisals of life-extending end of life treatments and recent changes to the Cancer Drugs Fund. He then presented the findings of a review of the empirical literature on end of life-related preferences (featured in a previous blog).
The presentation concluded with a discussion of recent additions to the evidence base that have sought to address some of the limitations and ambiguities in the earlier research on this topic. Koonal highlighted three innovative studies led by researchers in the Netherlands, Denmark and Scotland. The latter was a focus of a London Health Economics Group seminar hosted by OHE in November.
For more information on OHE’s research on social values, contact Koonal Shah.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!